CMPD
CompuMed, Inc.
OTC Markets OTCID Healthcare United States
6,39 $US
+0.00% today
+35.10% YTD · +43.27% 1Y
0
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
0
Hedge funds tracked
Latest available SEC 13F filings
49
/ 100
MIXED

Analysis CompuMed, Inc. (CMPD) — Kairos Score 49/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About CompuMed, Inc.

CompuMed, Inc. provides diagnostic telemedicine solutions in the United States. It offers a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including echocardiogram, ECG/EKG, nuclear cardiology, cardiac CT and MRI, MUGA scan, cardiac catheterization, pediatric, stress testing, and holter/event monitor; and teleradiology reading and interpretation services, such as X-ray, ultrasound, chest CT, MRI, measurement, and on demand consult. The company also provides telepathology reading and interpretation services for liver, renal/kidney, pancreas, and tissue; and pulmonology reading and interpretation services comprising bronchoscopy, 3D rendering, measurement, and lung management. In addition, it provides support services; and operates CompuMed, a cloud-based portal that allows to view, manage, and share your case data. The company serves organ donation/transplant, correctional healthcare, hospitals, and rural hospital telemedicine medicines. CompuMed, Inc. was incorporated in 1986 and is headquartered in Los Angeles, California.

Key info

👔
CEO
Mr. Lee Keddie
📍
HQ
5777 West Century Blvd., Suite 360, Los Angeles, CA, 90045, United States
👥
Employees
8
💰
Market cap
8 496 911,00 $US
💸
Dividend yield
—

🕴️ Insider activity (90 days)

0 transactions — 0 buys and 0 sales reported by CompuMed, Inc. executives.

🏦 Hedge Funds

0 institutional funds report a position on CMPD in their latest SEC quarterly filing.

📰 Recent news

1 recent articles on CMPD.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as CompuMed, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of CMPD on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 0 insider transactions over 90 days
✅ All 0 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year